Small intestine transplantation today

Langenbeck's Archives of Surgery

Volumn 392, Issue 3, 2007, Pages 227-238

  Braun, Felix ^a   Broering, Dieter ^a   Faendrich, Fred ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Intestinal transplantation; Short bowel syndrome; Total parenteral nutrition

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; BASILIXIMAB; BILIRUBIN; CHOLESTIN; CHOLESTIN SULFATE; CYCLOSPORIN; DACLIZUMAB; DOPAMINE; GANCICLOVIR; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MANGANESE; METHYLPREDNISOLONE; METOCLOPRAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOSTIGMINE; NORADRENALIN; OKT 3; PREDNISOLONE; PROSTAGLANDIN E2; PROTON PUMP INHIBITOR; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ANASTOMOSIS INSUFFICIENCY; ANEMIA; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; CALCIUM OXALATE STONE; CANDIDIASIS; CARDIOVASCULAR RISK; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHOLELITHIASIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHING DISEASE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; ENTERIC FEEDING; ENTERITIS; ENTEROSTOMY; EPIDURAL CATHETER; FRAGILITY FRACTURE; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; GERMANY; GLAUCOMA; GRAFT REJECTION; GRAFT SURVIVAL; HERPES VIRUS INFECTION; HUMAN; HYPERLIPIDEMIA; HYPERMAGNESEMIA; HYPERPLASIA; HYPERTENSION; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; INTESTINE FAILURE; INTESTINE GRAFT REJECTION; INTESTINE TRANSPLANTATION; INTRAHEPATIC CHOLESTASIS; JEJUNOSTOMY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEUKOPENIA; LOW DRUG DOSE; LYMPHOCYTE; LYMPHOCYTOPENIA; LYMPHOPROLIFERATIVE DISEASE; LYPHOPLASMACYTIC HYPERPLASIA; MEDICAL EXAMINATION; MICROBIAL COLONIZATION; NEPHROTOXICITY; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; OBESITY; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PANCREATICODUODENECTOMY; PARENTERAL NUTRITION; PATIENT REFERRAL; PEPTIC ULCER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REPERFUSION INJURY; SEPTICEMIA; SHORT BOWEL SYNDROME; SIDE EFFECT; SMALL INTESTINE DISEASE; SMALL INTESTINE RESECTION; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TOTAL PARENTERAL NUTRITION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; WOUND HEALING IMPAIRMENT;

ADULT; CHILD; COSTS AND COST ANALYSIS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL DISEASES; INTESTINE, SMALL; PARENTERAL NUTRITION, TOTAL; QUALITY OF LIFE; TIME FACTORS; TRANSPLANTATION;

EID: 34247633547     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-006-0134-5     Document Type: Article

References (105)

1. Margreiter R (1997) The history of intestinal transplantation. Transplant Rev 11(1):9-21
2. Grant D (1999) Intestinal transplantation: 1997 report of the international registry. Intestinal transplant registry. Transplantation 67(7):1061-1064
3. Caicedo JC, Iyer KR (2005) Recipient selection for intestinal transplantation. Curr Opin Organ Transpl 10:116-119
4. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C (1999) Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 117(5):1043-1050
5. Buchman AL, Scolapio J, Fryer J (2003) AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 124(4):1111-1134
6. Todo S, Reyes J, Furukawa H, Abu-Elmagd K, Lee RG, Tzakis A et al (1995) Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 222(3):270-280
7. Koffeman GI, van Gemert WG, George EK, Veenendaal RA (2003) Classification, epidemiology and aetiology. Best Pract Res Clin Gastroenterol 17(6):879-893
8. Van Gossum A, Peeters I, Lievin V (1999) Home parenteral nutrition in adults: the current use of an experienced method. Acta Gastroenterol Belg 62(2):201-209
9. Pironi L, Hebuterne X, Van Gossum A, Messing B, Lyszkowska M, Colomb V et al (2006) Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol 101 (7):1633-1643
10. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE (1968) Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 64(1):134-142
11. Messing B, Lemann M, Landais P, Gouttebel MC, Gerard-Boncompain M, Saudin F et al (1995) Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 108(4):1005-1010
12. Scolapio JS, Fleming CR, Kelly DG, Wick DM, Zinsmeister AR (1999) Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc 74(3):217-222
13. Pironi L, Paganelli F, Labate AM, Merli C, Guidetti C, Spinucci G et al (2003) Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre. Dig Liver Dis 35(5):314-324
14. Schalamon J, Mayr JM, Hollwarth ME (2003) Mortality and economics in short bowel syndrome. Best Pract Res Clin Gastroenterol 17(6):931-942
15. Goulet O, Baglin-Gobet S, Talbotec C, Fourcade L, Colomb V, Sauvat F et al (2005) Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 15(2):95-101
16. Buchman AL (2004) The medical and surgical management of short bowel syndrome. MedGenMed Gastroenterol 6(2):1-7
17. Terra RM, Plopper C, Waitzberg DL, Cukier C, Santoro S, Martins JR et al (2000) Remaining small bowel length: association with catheter sepsis in patients receiving home total parenteral nutrition: evidence of bacterial translocation. World J Surg 24(12):1537-1541
18. Buchman AL, Moukarzel A, Goodson B, Herzog F, Pollack P, Reyen L et al (1994) Catheter-related infections associated with home parenteral nutrition and predictive factors for the need for catheter removal in their treatment. JPEN J Parenter Enteral Nutr 18(4):297-302
19. O'Keefe SJ, Burnes JU, Thompson RL (1994) Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. JPEN J Parenter Enteral Nutr 18(3):256-263
20. Stratov I, Gottlieb T, Bradbury R, O'Kane GM (1998) Candidaemia in an Australian teaching hospital: relationship to central line and TPN use. J Infect 36(2):203-207
21. Braun F, Platz KP, Faendrich F, Kremer B, Mueller AR (2004) Management of venous access problems before and after intestinal transplantation: case reports. Transplant Proc 36 (2):392-393
22. Iyer KR, Horslen S, Torres C, Vanderhoof JA, Langnas AN (2004) Functional liver recovery parallels autologous gut salvage in short bowel syndrome. J Pediatr Surg 39(3):340-344
23. Fryer JP (2001) The role of intestinal transplantation in the management of intestinal failure. Curr Gastroenterol Rep 3 (4):334-342
24. Bueno J, Ohwada S, Kocoshis S, Mazariegos GV, Dvorchik I, Sigurdsson L et al (1999) Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 34(1):27-32
25. Horslen S (2004) Organ allocation for liver-intestine candidates. Liver Transplant 10(10 Suppl 2):S86-S89
26. Thompson JS (1996) The role of prophylactic cholecystectomy in the short-bowel syndrome. Arch Surg 131(5):556-559
27. Nightingale JM (2003) Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol 17 (6):907-929
28. Nightingale JM (2003) The medical management of intestinal failure: methods to reduce the severity. Proc Nutr Soc 62(3):703-710
29. Banerjee A, Warwicker P (2002) Acute renal failure and metabolic disturbances in the short bowel syndrome. QJM 95 (1):37-40
30. Boncompain-Gerard M, Robert D, Fouque D, Hadj-Aissa A (2000) Renal function and urinary excretion of electrolytes in patients receiving cyclic parenteral nutrition. JPEN J Parenter Enteral Nutr 24(4):234-239
31. Buchman AL, Moukarzel A, Ament ME, Gornbein J, Goodson B, Carlson C et al (1993) Serious renal impairment is associated with long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 17(5):438-444
32. Lopez I, Buchman AL (2000) Metabolic bone disease in IBD. Curr Gastroenterol Rep 2(4):317-322
33. Cohen-Solal M, Baudoin C, Joly F, Vahedi K, D'Aoust L, De Vernejoul MC et al (2003) Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res 18(11):1989-1994
34. Klein GL (1998) Metabolic bone disease of total parenteral nutrition. Nutrition 14(1):149-152
35. Van Gossum A, Vahedi K, Abdel M, Staun M, Pertkiewicz M, Shaffer J et al (2001) Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey. Clin Nutr 20(3):205-210
36. Leicher CR, Mezoff AG, Hyams JS (1991) Focal cerebral deficits in severe hypomagnesemia. Pediatr Neurol 7(5):380-381
37. Fagan C, Phelan D (2001) Severe convulsant hypomagnesaemia and short bowel syndrome. Anaesth Intensive Care 29(3):281-283
38. Fitzgerald K, Mikalunas V, Rubin H, McCarthey R, Vanagunas A, Craig RM (1999) Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 23(6):333-336
39. Szkudlarek J, Jeppesen PB, Mortensen PB (2000) Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Gut 47:199-205
40. Scolapio JS, Camilleri M, Fleming CR et al (1997) Effect of growth hormone, glutamine, and diet on adaptation in short bowel syndrome: a randomized, controlled trial. Gastroenterology 113:1074-1081
41. Beaugerie L, Carbonnel F, Hecketsweiler B et al (1997) Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with short-bowel. Aliment Pharmacol Ther 11:741-746 (Abstract)
42. Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR et al (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54(9):1224-1231
43. Jeppesen PB (2006) The use of hormonal growth factors in the treatment of patients with short-bowel syndrome. Drugs 66(5):581-589
44. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW (1995) A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 222(3):243-254
45. Bianchi A (1999) Experience with longitudinal intestinal lengthening and tailoring. Eur J Pediatr Surg 9(4):256-259
46. Carlson GL (2003) Surgical management of intestinal failure. Proc Nutr Soc 62(3):711-718
47. Wales PW (2004) Surgical therapy for short bowel syndrome. Pediatr Surg Int 20(9):647-657
48. Panis Y, Messing B, Rivet P, Coffin B, Hautefeuille P, Matuchansky C et al (1997) Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg 225(4):401-407
49. Kim HB, Fauza D, Garza J, Oh JT, Nurko S, Jaksic T (2003) Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 38(3):425-429
50. Chang RW, Javid PJ, Oh JT, Andreoli S, Kim HB, Fauza D et al (2006) Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome. Ann Surg 243(2):223-228
51. Duggan C, Piper H, Javid PJ, Valim C, Collier S, Kim HB et al (2006) Growth and nutritional status in infants with short-bowel syndrome after the serial transverse enteroplasty procedure. Clin Gastroenterol Hepatol 4(10):1237-1241
52. Javid PJ, Kim HB, Duggan CP, Jaksic T (2005) Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg 40(6):1019-1023
53. Gracy M (1979) The contaminated small bowel syndrome: pathogenesis, diagnosis, and treatment. Am J Clin Nutr 32:234-243
54. Manez R, Kusne S, Green M, Abu-Elmagd K, Irish W, Reyes J et al (1995) Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 59(7):1010-1014
55. Todo S, Tzakis AG, Abu-Elmagd K, Reyes J, Nakamura K, Casavilla A et al (1992) Intestinal transplantation in composite visceral grafts or alone. Ann Surg 216(3):223-233
56. Mueller AR, Rao PN, Snyder JT, Hoffman RA, Schraut WH (1993) Hyaluronic acid and purine nucleoside phosphorylase in vascular and luminal effluents of small bowel grafts as parameters of preservation injury. Transplantation 55(6):1225-1229
57. Mueller AR, Platz KP, Neuhaus P, Lee KK, Schraut WH (1996) Goals of small bowel preservation. Transplant Proc 28(5):2633-2635
58. Muller AR, Nalesnik M, Platz KP, Langrehr JM, Hoffman RA, Schraut WH (1994) Evaluation of preservation conditions and various solutions for small bowel preservation. Transplantation 57(5):649-655
59. Testa G, Benedetti E (2006) Role of living donor bowel transplantation in the treatment of intestinal failure in adults. Curr Opin Organ Transplant 11(3):247-250
60. Testa G, Panaro F, Schena S, Holterman M, Abcarian H, Benedetti E (2004) Living related small bowel transplantation: donor surgical technique. Ann Surg 240(5):779-784
61. Gruessner RW, Sharp HL (1997) Living-related intestinal transplantation: first report of a standardized technique. Transplantation 64:1605-1607
62. Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T et al (2003) Report of the intestine transplant registry: a new era has dawned. Ann Surg 241(4):607-613
63. Fryer J, Pellar S, Ormond D, Koffron A, Abecassis M (2003) Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl 9(7):748-753
64. Fecteau A, Atkinson P, Grant D (2001) Early referral is essential for successful pediatric small bowel transplantation: The Canadian experience. J Pediatr Surg 36(5):681-684
65. Fishbein TM, Kaufman SS, Florman SS, Gondolesi GE, Schiano T, Kim-Schluger L et al (2003) Isolated intestinal transplantation: proof of clinical efficacy. Transplantation 76(4):636-640
66. Sudan DL, Kaufman SS, Shaw BW Jr, Fox IJ, McCashland TM, Schafer DF et al (2000) Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 95(6):1506-1515
67. Cicalese L, Rastellini C, Sileri P, Abcarian H, Benedetti E (2001) Segmental living related small bowel transplantation in adults. J Gastrointest Surg 5:168-172
68. Selvaggi G, Tzakis AG (2006) New trends in multivisceral transplantation. Curr Opin Organ Transplant 11(3):263-268
69. Fishbein TM, Gondolesi GE, Kaufman SS (2003) Intestinal transplantation for gut failure. Gastroenterology 124(6):1615-1628
70. Ringe B, Braun F (2005) Immunosuppresive drugs. Encyclopedia of life sciences. Wiley. DOI 10.1038/npg.els0003996
71. Fishbein TM, Matsumoto CS (2005) Regimens for intestinal transplant immunosuppression. Curr Opin Organ Transplant 10:120-123
72. Ueno T, Kato T, Gaynor J, Velasco M, Selvaggi G, Nishida S et al (2006) Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. Transplant Proc 38(6):1762-1764
73. Platz KP, Braun F, Fandrich F, Kremer B, Mueller AR (2005) IL-2 antagonists: the European perspective. Transplant Proc 37(4):1783-1784
74. Sudan DL, Chinnakotla S, Horslen S, Iyer K, Fox I, Shaw B et al (2002) Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Transplant Proc 34(3):940-941
75. Garcia M, Weppler D, Mittal N, Nishida S, Kato T, Tzakis A et al (2004) Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc 36(2):323-324
76. Ruiz P, Soares MF, Garcia M, Nicolas M, Kato T, Mittal N et al (2004) Lymphoplasmacytic hyperplasia (possibly pre-PTLD) has varied expression and appearance in intestinal transplant recipients receiving Campath immunosuppression. Transplant Proc 36(2):386-387
77. Fishbein TM, Florman S, Gondolesi G, Schiano T, LeLeiko N, Tschernia A et al (2002) Intestinal transplantation before and after the introduction of sirolimus. Transplantation 73(10):1538-1542
78. Groetzner J, Kur F, Spelsberg F, Behr J, Frey L, Bittmann I et al (2004) Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant 23(5):632-638
79. Turner D, Martin S, Ngan BY, Grant D, Sherman PM (2006) Anastomotic ulceration following small bowel transplantation. Am J Transplant 6(1):236-240
80. Paramesh AS, Grosskreutz C, Florman SS, Gondolesi GE, Sharma S, Kaufman SS et al (2004) Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. Transplantation 77(1):129-131
81. Tzakis AG, Weppler D, Khan MF, Koutouby R, Romero R, Viciana AL et al (1998) Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation. Transplant Proc 30(6):2677-2679
82. Loinaz C, Kato T, Nishida S, Weppler D, Levi D, Dowdy L et al (2006) Bacterial infections after intestine and multivisceral transplantation. The experience of the University of Miami (1994-2001). Hepatogastroenterol 53(68):234-242
83. Benedetti E, Holterman M, Asolati M, Di Domenico S, Oberholzer J, Sankary H et al (2006) Living related segmental bowel transplantation: from experimental to standardized procedure. Ann Surg 244(5):694-699
84. Behrend M (2001) Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Safety 24(9):645-663
85. Behrend M, Braun F (2005) Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil. Drugs 65(8):1037-1050
86. Braun F, Platz K, Faendrich F, Mueller AR (2006) Dünndarm- transplantation. In: Siewert JR, Rothmund M, Schumpelick V (eds) Praxis der Viszeralchirurgie. Springer, Berlin Heidelberg, New York, pp. 415-429
87. Kato T, O'Brien CB, Nishida S, Hoppe H, Gasser M, Berho M et al (1999) The first case report of the use of a zoom video-endoscope for the evaluation of small bowel graft mucosa in a human after intestinal transplantation. Gastrointest Endosc 50(2):257-261
88. Goulet O, Brousse N, Ricour C (1994) Pathology of human intestinal transplantation. In: Grant D, Wood RFM (eds) Small bowel transplantation. Edward Arnold, Great Britain, pp. 112-120
89. Kato T, Mizutani K, Terasaki P, Quentin C, Selvaggi G, Thompson J et al (2006) Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. Transplant Proc 38(6):1735-1737
90. Mueller AR, Pascher A, Platz KP, Braun F, Fandrich F, Rayes N et al (2004) Immunosuppression following intestinal transplantation. Transplant Proc 36(2):325-328
91. Pascher A, Radke C, Dignass A, Schulz RJ, Veltzke-Schlieker W, Adler A et al (2003) Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation. Transplantation 76(3):615-618
92. Green M, Reyes J, Jabbour N, Yunis E, Putnam P, Todo S et al (1996) Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant Proc 28(5):2759-2760
93. Reyes J, Tzakis AG, Bonet H, Green M, Yunis E, Nalesnik M et al (1994) Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc 26(3):1426-1427
94. Berney T, Delis S, Kato T, Nishida S, Mittal NK, Madariaga J et al (2002) Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation 74(7):1000-1006
95. Oertel SH, Anagnostopoulos I, Hummel MW, Jonas S, Riess HB (2002) Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease. Br J Haematol 118(4):1120-1123
96. Oertel SH, Papp-Vary M, Anagnostopoulos I, Hummel MW, Jonas S, Riess HB (2003) Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide. Br J Haematol 123(5):830-835
97. Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-Vary M, Babel N et al (2005) Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 5(12):2901-2906
98. Chaney M (2004) Financial considerations insurance and coverage issues in intestinal transplantation. Prog Transplant 14(4):312-320
99. Abu-Elmagd KM, Reyes J, Fung JJ, Mazariegos G, Bueno J, Janov C et al (1999) Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc 31(1-2):582-584
100. Jeppesen PB, Langholz E, Mortensen PB (1999) Quality of life in patients receiving home parenteral nutrition. Gut 44(6):844-852
101. DiMartini A, Rovera GM, Graham TO, Furukawa H, Todo S, Funovits M et al (1998) Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 22(6):357-362
102. Rovera GM, DiMartini A, Schoen RE, Rakela J, Abu-Elmagd K, Graham TO (1998) Quality of life of patients after intestinal transplantation. Transplantation 66(9):1141-1145
103. Sudan D, Horslen S, Botha J, Grant W, Torres C, Shaw B Jr et al (2004) Quality of life after pediatric intestinal transplantation: the perception of pediatric recipients and their parents. Am J Transplant 4(3):407-413
104. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ (2003) A schema for histologic grading of small intestine allograft acute rejection. Transplantation 75(8):1241-1248
105. Ruiz P, Weppler D, Nishida S, Kato T, Selvaggi G, Levi D et al (2006) International grading scheme for acute rejection in small bowel transplantation: implementation and experience at the University of Miami. Transplant Proc 38(6):1683-1684